MedTrace Logo

Effects of Different Foot Structures on Plantar Fasciitis and Therapeutic Footwear Intervention

NCT01363375 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2011-06-01

No results posted yet for this study

Summary

Excessive repetitive loading concentrating upon plantar fascia is considered as the most influential factor in plantar fasciitis development. Abnormal foot structure may lead to high risk of plantar fasciitis. However, the biomechanical factor that may cause plantar fasciitis has not been thoroughly investigated. Orthotic device is a common treatment used for plantar fasciitis. However, there is no direct and quantitative data, such as stress and strain distribution of plantar fascia for patient with foot orthosis during gait. Therefore, the aim of this three-year project study is to investigate the biomechanical mechanism of different foot structures and to understand the biomechanical response of plantar fascia during stance phase of gait cycle by dynamic finite element analysis, gait analysis as well as plantar pressure measurement. In addition, the efficacy of foot orthoses will be evaluated by the same research process. The hypotheses are that flat foot and high arch foot may result in higher stress and strain upon plantar fascia during gait; the foot orthosis, such as total contact insole, carbon fiber plate and rocker bottom sole, would reduce stress and strain distribution around the calcaneal medial tuberosity; rigid and curved geometric bottom will be able to relief plantar fascia stretching during push-off phase.

Conditions

  • Fasciitis

Interventions

PROCEDURE

Foot orthosis, footwear

flat insole, total contact insole , carbon fiber plate; general shoe and rocker sole shoe

PROCEDURE

Foot orthosis, Footwear

flat insole, total contact insole, carbon fiber plate; general shoe and rocker sole shoe

PROCEDURE

Foot orthosis, footwear

flat insole, total contact insole, carbon fiber plate; general shoe and rocker sole shoe

Sponsors & Collaborators

  • National Science and Technology Council, Taiwan

    collaborator OTHER_GOV

  • Chang Gung Memorial Hospital

    lead OTHER

Principal Investigators

  • Chih-Chin Hsu, MD, PhD · Chang Gung Memorial Hospital, Keelung

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2011-07-31
Completion
2011-07-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01363375 on ClinicalTrials.gov